Atria Plc Interim Report 1 January – 30 June 2016

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Atria Plc Interim Report 1 January – 30 June 2016

Seinäjoki, Finland, 2016-07-21 07:00 CEST (GLOBE NEWSWIRE) -- Atria Plc, Interim Report, 21 July 2016 at 8.00 am ATRIA PLC INTERIM REPORT 1 JANUARY  – 30 JUNE 2016 Atria invests in growth April–June 2016 - Consolidated net sales totalled EUR 341.3 million (EUR 337.5 million). - Consolidated EBIT was EUR 6.1 million (EUR 8.4 million), or 1.8% (2.5%) of net sales. - Lagerberg i Norjeby AB's business operations were transferred to Atria as of the beginning of May. Atria's annual net sales are expected to grow by about EUR 30 million. In June, Atria decided to invest EUR 14 million in Lagerbergs’ chicken production in Sweden. - Atria will acquire a majority stake in Well-Beef Kaunismaa Ltd subject to the approval of the Finnish Competition and Consumer Authority. Atria's annual net sales are expected to grow by about EUR 40 million. - Atria Finland's new pig cutting plant has entered the start-up phase. - Atria sold a pig farm in Estonia and estates that it no longer needed in Estonia and Sweden. January–June 2016 - Consolidated net sales totalled EUR 655.8 million (EUR 652.1 million). - Consolidated EBIT was EUR 7.8 million (EUR 9.1 million), which is 1.2 per cent (1.4%) of net sales. - EBIT growth was slowed by decreased sales prices, the costs of starting up the pig cutting plant and the costs incurred in taking over new businesses.  

  Q2 Q2 H1 H1  
EUR million 2016 2015 2016 2015 2015
Net sales          
   Atria Finland 233.9 233.7 458.6 445.9 929.0
   Atria Scandinavia 88.8 80.3 164.5 165.4 330.5
   Atria Russia 17.6 21.5 31.2 37.3 75.1
   Atria Baltic 9.2 8.9 16.9 16.5 32.9
   Eliminations -8.3 -6.8 -15.5 -13.1 -27.4
Total net sales 341.3 337.5 655.8 652.1 1,340.2
           
EBIT          
   Atria Finland 3.0 4.7 4.7 6.6 29.8
   Atria Scandinavia 3.5 2.5 4.2 4.4 12.8
   Atria Russia 0.1 1.9 -0.6 -0.3 -0.2
   Atria Baltic -0.3 0.2 -0.5 0.1 -9.0
   Unallocated -0.2 -0.9 0.0 -1.6 -4.4
EBIT, total 6.1 8.4 7.8 9.1 28.9
EBIT, % 1.8 % 2.5 % 1.2 % 1.4 % 2.2 %
           
Profit before taxes 4.8 6.0 4.5 4.4 20.1
Earnings per share, EUR 0.13 0.18 0.10 0.11 0.49
           
EBIT includes items affecting comparability:        
Goodwill impairment - - - - -9.1
Pig farms sale -1.0 1.9 -1.0 1.9 1.9
Sale of the real estate company 1.4 - 1.4 - -
Adjusted EBIT 5.7 6.5 7.4 7.2 36.1

Juha Gröhn, CEO "Fierce price competition has continued in Atria's home markets of Finland, Sweden, Estonia, Russia and Denmark. The product groups currently facing the toughest price competition are meat products and pork in Finland and Estonia, as well as some meat-product segments in Scandinavia.  During the spring, raw-material markets turned a corner as the price of pork began to rise in Europe. This change will increase the pressure for price rises among ready-made products. During the first half of the year, Atria's Healthy Growth strategy was implemented systematically. Atria is looking for growth, both organic growth and expansion through acquisitions. Atria acquired a foothold in the expanding Swedish poultry market by purchasing Lagerbergs. The transaction was complemented by the initiation of a EUR 14 million investment programme in the newly-acquired company. The aim is to make Lagerbergs a strong player on Nordic poultry markets by joining forces with Atria Finland's poultry operations. In Finland, Atria will purchase a majority stake in Well-Beef Kaunismaa Ltd, a company that primarily sells raw meat products and beef on Food Service markets. Conclusion of the deal is subject to the approval of the competition authorities. Atria's most significant investment is the modernisation of the Nurmo pig cutting plant. Cutting will become more efficient and annual costs will decrease by approximately EUR 8 million in comparison with previous figures. Commissioning of the plant began in May. Commissioning of the plant is currently increasing cutting costs and additional costs will decrease as the commissioning gathers pace. Development of the Sibylla concept is continuing at pace, particularly in Russia. Sales are showing good development and there are currently more than 2,500 sales outlets in Russia. During the first half of the year, Atria concluded three separate transactions to sell premises and businesses that it no longer needed. The Linnamäe pig farm and Vastse-Kuuste production plant in Estonia found new owners, as did the logistics unit in Gothenburg." April–June 2016 Atria Group’s net sales for April–June totalled EUR 341.3 million (EUR 337.5 million). EBIT amounted to EUR 6.1 million (EUR 8.4 million). Adjusted EBIT was EUR 5.7 million (EUR 6.5 million). Sales volumes increased during the period under review. The decline in sales prices due to price competition has slowed down the growth in net sales and EBIT. Sales in Finland were weighted towards exports, wholesale and industrial sales, which weakened EBIT. The Swedish Competition Authority and Consumer Agency unconditionally approved Atria's acquisition of the entire share capital of Lagerberg i Norjeby AB (Lagerbergs), a Swedish poultry company. The agreement between Atria and Lagerbergs was confirmed at the end of April and the business operations were transferred to Atria as of the start of May.  The purchase price was approximately EUR 18 million, and it was paid in cash. Atria's annual net sales are expected to grow by about EUR 30 million. The transaction expands Atria's business into the Swedish poultry processing market. In June, Atria’s Board of Directors approved a long-term investment programme worth EUR 14 million for the development of Lagerbergs’ operations. The investments will be devoted to improving the entire production chain, from chicken rearing and industrial production to strengthening Lagerbergs’ brand. The investments will take place in the period from 2016 to 2018. Negotiations with the personnel concerning the investment project in Atria Finland's pig cutting plant located in Nurmo were concluded. The cutting plant’s operations will be reorganised and working methods revised. As a result of these arrangements, staffing will be reduced by 80 person-years by the end of 2016. The reduction in personnel will be implemented by means of natural attrition, internal transfers and pension arrangements. In addition, the plant will no longer subcontract cutting work. The value of the investment is approximately EUR 36 million, and it is expected to generate annual cost savings of some EUR 8 million in the plant’s operations. These savings will be realised in full as of the beginning of 2018. The first phase of the pig cutting plant will be commissioned this year. Atria Finland will purchase 70 per cent of Well-Beef Kaunismaa Ltd's share capital. Well-Beef's business focuses on beef processing and wholesale business. Atria's annual net sales are expected to increase by approximately EUR 40 million. The transaction requires the approval of the Finnish Competition and Consumer Authority. Efforts will be made to conclude the transaction during the third quarter of this year. Atria sold the Linnamäe pig farm located in Northern Estonia. The sale of the Linnamäe pig farm gave rise to a sales loss of approximately EUR 1 million. The pig farm was transferred into new ownership on 29 April 2016. Atria centralised its industrial operations in Estonia at the Valga factory. Production of meat products was transferred from the Vastse-Kuuste factory to Valga and the real estate was sold. The sale had no impact on the company’s results. Production rearrangements were concluded by the end of the second quarter. The measures are expected to generate annual savings of approximately EUR 0.5 million. Atria centralised its logistics operations in Sweden by moving them from Gothenburg to the Malmö plant.  The logistics centre in Gothenburg was sold for a profit of EUR 1.4 million. Atria Finland's net sales for April–June totalled EUR 233.9 million (EUR 233.7 million). The proportion of exports, wholesale and industrial sales of total sales volume has increased. Sales to retail and Food Service customers decreased correspondingly, which resulted in decreased market share. Tough price competition in the retail sector and a weakened sales structure weighed down EBIT. EBIT amounted to EUR 3.0 million (EUR 4.7 million). Atria Scandinavia’s net sales for April–June totalled EUR 88.8 million (EUR 80.3 million). EBIT amounted to EUR 3.5 million (EUR 2.5 million). Adjusted EBIT was EUR 2.1 million (EUR 2.5 million). Net sales increased thanks to good sales trends in Sweden and the purchase of Lagerbergs. Atria Russia's net sales for April–June totalled EUR 17.6 million (EUR 21.5 million). In the local currency, net sales grew by 3 per cent. EBIT amounted to EUR 0.1 million (EUR 1.9 million). Adjusted EBIT was EUR 0.1 million (EUR 0.1 million). Atria Baltic's net sales for April–June totalled EUR 9.2 million (EUR 8.9 million). EBIT was EUR -0.3 million (EUR 0.2 million). Adjusted EBIT was EUR 0.7 million (EUR 0.2 million). Sales volumes were good, particularly in May and June. Sales of new minced meat products got off to a promising start. Cost-efficiency has improved from the previous year. January–June 2016 Atria Group’s net sales for January–June totalled EUR 655.8 million (EUR 652.1 million). EBIT amounted to EUR 7.8 million (EUR 9.1 million). Adjusted EBIT was EUR 7.4 million (EUR 7.2 million). EBIT growth was slowed by decreased sales prices, the costs of starting up the pig cutting plant and the costs incurred in taking over new businesses. Atria Finland’s net sales for January–June totalled EUR 458.6 million (EUR 445.9 million), up by EUR 12.8 million year-on-year. Increased sales volumes at the beginning of the year enabled net sales to grow. Average sales prices have decreased on home markets in comparison with the equivalent period last year. EBIT amounted to EUR 4.7 million (EUR 6.6 million). Atria Scandinavia’s net sales for January–June totalled EUR 164.5 million (EUR 165.4 million). EBIT amounted to EUR 4.2 million (EUR 4.4 million). Adjusted EBIT was EUR 2.8 million (EUR 4.4 million). In the first half of the year, EBIT was weighed down by a weak sales structure. Atria Russia’s net sales for January–June totalled EUR 31.2 million (EUR 37.3 million). In the local currency, net sales grew by 1.3 per cent. EBIT was EUR -0.6 million (EUR -0.3 million). Adjusted EBIT was EUR -0.6 million (EUR -2.2 million).  EBIT improved thanks to efficiency improvement measures and a revamped product selection. Atria Baltic’s net sales for January–June totalled EUR 16.9 million (EUR 16.5 million). EBIT was EUR -0.5 million (EUR 0.1 million). Adjusted EBIT was EUR 0.5 million (EUR 0.1 million). Atria's retail sales volumes showed positive development in the first half of the year. Sales of fresh and marinated meat showed particularly strong improvement.   

Key indicators      
EUR million 30.6.16 30.6.15 31.12.15
       
Equity/share, EUR 13.95 14.14 14.16
Interest-bearing liabilities 235.9 240.1 199.6
Equity ratio, % 44.8 % 45.1 % 47.4 %
Net gearing, % 58.1 % 58.8 % 48.3 %
Gross investments in fixed assets 42.8 28.8 56.9
Gross investments, % of net sales 6.5 % 4.4 % 4.2 %
Average personnel (FTE) 4,340 4,399 4,271
       
The principles for calculating key indicators were presented in the 2015 annual financial statements.

   Outlook for the future Consolidated EBIT was EUR 28.9 million in 2015. In 2016, EBIT is expected to be better than in 2015. In 2016, net sales are expected to grow. Disclosure Atria Plc complies with the disclosure procedure in accordance with standard 5.2b of the Financial Supervisory Authority and publishes its financial statement release for 1 January to 30 June 2016 as an attachment to this company announcement. The full release is available on the company’s website at www.atria.com. For more information, please contact: Juha Gröhn, CEO, Atria Plc, tel. +358 400 684224. Invitation to press conference A press conference will be held in Finnish today, 21 July 2016, at 10:30 am at Atria Plc’s Helsinki office, Läkkisepäntie 23, Helsinki. The presentation material will be available on the company’s website (www.atria.com) after the publication of the financial statements and as an attachment to this company announcement. ATRIA PLC Boad of Directors DISTRIBUTION Nasdaq Helsinki Ltd Major media www.atria.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 135

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 220

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 210

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 318

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 269

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 283

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 406

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 180

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 103

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 235

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading

Top 5 Most Recently Viewed Articles

Kulicke & Soffa Announces Conference Call for Fiscal Results

Updated Category News Views 122

Kulicke & Soffa Schedules Conference Call Kulicke and Soffa Industries, Inc. (NASDAQ: KLIC), a leading name in semiconductor assembly technology, has announced a conference call to discuss its third fiscal quarter financial results and business outlook. The call is set for a future date, highlighting the company's commitment to transparency and communication with its...

Continue Reading
ARMOUR Residential REIT Launches Major Stock Offering for Growth

Updated Category News Views 162

ARMOUR Residential REIT Enters Public Stock Offering ARMOUR Residential REIT, Inc. (NYSE: ARR and ARR-PRC) has officially announced an underwritten public offering of 18,500,000 shares of common stock. The company is poised to grant underwriters an additional option to purchase up to 2,775,000 shares, making this a significant move for ARMOUR as it aims to enhance its...

Continue Reading
Celebrate Mother's Day with a Unique Brunch at Cannon + Belle

Updated Category News Views 195

Cannon + Belle Offers a Memorable Mother's Day Brunch Cannon + Belle at Hilton Austin is excited to announce an elevated Mother's Day brunch that promises to create unforgettable memories. This year, the restaurant will be hosting a special brunch event aimed at honoring mothers and all they do. With an impressive menu curated by the talented Chef Gereamy Cater, guests...

Continue Reading
Figma's Shares Surge in IPO But Valuation Remains a Concern

Updated Category News Views 244

Figma's Impressive IPO Performance Figma Inc. (NYSE: FIG) has captured significant investor attention following its explosive debut in the stock market. After launching its initial public offering, the company's shares skyrocketed by over 250%, marking a remarkable milestone for the firm. The stock began trading at a price of $33 per share, leading to approximately $1.2...

Continue Reading
Journey Medical Corporation's Emrosi Launch for Rosacea Relief

Updated Category News Views 215

Journey Medical Corporation Introduces Emrosi for Rosacea Treatment Journey Medical Corporation, a key player in the dermatological pharmaceutical industry, has recently launched Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules), designed for the effective treatment of rosacea. The product, featuring a unique formulation of 10 mg immediate release and...

Continue Reading